Valtrex Valacyclovir Warnings & Precautions

Filed under: Valtrex - 14 Nov 2007
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), in some cases resulting in death, has occurred in patients with advanced HIV disease and also in allogeneic bone marrow transplant and renal transplant recipients participating in clinical trials of VALTREX at doses of 8 grams per day. Dosage reduction is recommended when administering VALTREX ...

Valtrex (Valacyclovir) Side Effects

Filed under: Valtrex - 14 Nov 2007
Frequently reported adverse events in clinical trials of VALTREX in healthy patients are listed in Tables 4 and 5. Table 4. Incidence (%) of Adverse Events in Herpes Zoster Study Populations Adverse Event VALTREX 1 gram t.i.d. (n = 967) Placebo (n = 195) Nausea...

Valacyclovir Caplets Dosage and Administration

Filed under: Valtrex - 14 Nov 2007
Valacyclovir Caplets may be given without regard to meals. Herpes Zoster: The recommended dosage of Valacyclovir for the treatment of herpes zoster is 1 gram orally 3 times daily for 7 days. Therapy should be initiated at the earliest sign or symptom of herpes zoster and is most effective when started ...

Valtrex Valacyclovir Indications

Filed under: Valtrex - 14 Nov 2007
Herpes Zoster Valtrex Valacyclovir is indicated for the treatment of herpes zoster (shingles). Genital Herpes: Valtrex Valacyclovir is indicated for the treatment or suppression of genital herpes in immunocompetent individuals and for the suppression of recurrent genital herpes in HIV-infected individuals. When Valtrex Valacyclovir is used as suppressive therapy in immunocompetent individuals ...

Valacyclovir Valtrex Clinical Trials

Filed under: Valtrex - 14 Nov 2007
Herpes Zoster Two randomized double-blind clinical trials in immunocompetent adults with localized herpes zoster were conducted. VALTREX was compared to placebo in patients less than 50 years of age, and to ZOVIRAX in patients greater than 50 years of age. All patients ...
« Previous PageNext Page »